Market Research Report
Europe Syndromic Multiplex Diagnostic Market - Industry Trends Forecast to 2027
|Published by||Data Bridge Market Research Private Limited||Product code||961987|
|Published||Content info||162 Pages
Delivery time: 1-2 business days
|Europe Syndromic Multiplex Diagnostic Market - Industry Trends Forecast to 2027|
|Published: August 1, 2020||Content info: 162 Pages||
Europe syndromic multiplex diagnostic market is projected to register a CAGR of 7.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Europe Syndromic Multiplex Diagnostic Market By Products and Services (Reagents & Consumables, Instruments & Accessories, Software & Services), Infection Type (Viral, Bacterial, Parasites, Fungal, Others, Disease (Respiratory Infections, Gastroenteritis, Sexually Transmitted Infections, Hepatitis, Tropical Fever, Meningitis, Childhood Infections, Immunosuppression, Eye Infections), Panels Type (Respiratory Panel, GI-Enteric Panel, Sexually Transmitted Disease Panel, Blood-Sepsis Panel, Meningitis Panel, Others), End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes, Physician Office Lab's, Others) Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Belgium, Russia, Turkey & Rest of Europe) Industry Trends and Forecast to 2027
Some of the major factors contributing to the growth of Europe Syndromic Multiplex Diagnostic market are
Growing prevalence of infection diseases
Growing adoption of molecular diagnostics and increasing demand for accurate and fast diagnostic results
GenMark Diagnostics, Inc.
QuantuMDx Group Ltd.
BioFire Diagnostics (a subsidiary of bioMerieux SA)
Bio-Rad Laboratories, Inc.
Thermo Fisher Scientific Inc.
Siemens Healthcare GmbH
F. Hoffmann-La Roche Ltd
Bosch Healthcare Solutions GmbH (a subsidiary of Robert Bosch GmbH)
Biocartis, Luminex Corporation